Search
for
Sort by
Research 331–360 of 1000+
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- Urinary steroid metabolome shows adrenal, gonadal, and neuroactive steroid dysregulation in adolescents with depression
- Case Report: Multimodal contact immunotherapy in alopecia areata: long-term clinical experience in the JAK inhibitor era
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alopecia areata: a randomized controlled study
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- Non-Neoplastic Disorders of Hair
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- Roles of steroid sulfatase in brain and other tissues
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Health consequences of anabolic steroids: a sexual-medicine perspective
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Relative binding affinity of novel steroids to androgen receptors in hamster prostate
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Anabolic-androgenic steroids and cardiovascular risk
- Structural studies of two solid steroid compounds
- Synthesis and activity of 8-substituted benzo[c]quinolizin-3-ones as dual inhibitors of human 5α-reductases 1 and 2
- Management of Cutaneous and Extracutaneous Side Effects of Smoothened Inhibitor Therapy for Advanced Basal Cell Carcinoma
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Aromatase inhibitor therapy and hair loss among breast cancer survivors
- 5-Alpha-Reductase Inhibitors and Combination Therapy